Creso Pharma könnte seine Korrektur vollendet haben, die auf die 77% Fibonaccie verlief.
LG
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
